November 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 01, 2025
The anti-aging market size is expected to rise from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 01, 2025
Based on market forecasts, the genome sequencing sector will expand from USD 22.63 billion in 2024 to USD 101.93 billion by 2034, experiencing a CAGR of 16.24%. In 2024, North America led the genome sequencing market, with consumables and next-generation sequencing as key segments. The clinical and academic research sectors dominated. Asia Pacific ...
November 01, 2025
Projections indicate the global acute myeloid leukemia treatment market will increase from USD 3.5 billion in 2024 to USD 9.62 billion by 2034, experiencing a CAGR of 10.64% over the next 10 years. In 2024, North America led the acute myeloid leukemia treatment market, with chemotherapy and hospital clinics dominating. Myeloblastic leukemia was mos...
November 01, 2025
According to market projections, the multiple myeloma sector is expected to grow from USD 27.75 billion in 2024 to USD 49.89 billion by 2034, reflecting a CAGR of 6.04%. In 2024, North America led the global multiple myeloma market, while Asia-Pacific is set for strong growth ahead. Immunomodulators dominated by drug class, but proteasome inhibitor...
November 01, 2025
Based on market forecasts, the monoclonal antibodies therapeutics sector will expand from USD 265.17 billion in 2024 to USD 1057.91 billion by 2034, experiencing a CAGR of 14.84%. In 2024, North America led the monoclonal antibody therapeutics market, with human mABs and cancer applications holding the largest shares. Asia Pacific is set for the fa...
November 01, 2025
Based on market forecasts, the pharma 4.0 sector will expand from USD 12.76 billion in 2024 to USD 72.58 billion by 2034, experiencing a CAGR of 19%. In 2024, North America led the Pharma 4.0 market, while Asia-Pacific is set for the fastest growth. Software dominated by type, but services will rise. AI & ML led in technology, with blockchain g...
November 01, 2025
According to market projections, the isotope sector is expected to grow from USD 6.09 billion in 2024 to USD 14.2 billion by 2034, reflecting a CAGR of 8.84%. In 2024, North America led the global isotope market, while Asia-Pacific is set for the fastest growth. Radioisotopes dominated, but stable isotopes are expected to rise. Diagnostics held the...
November 01, 2025
Market insights predict the global progesterone industry will increase from USD 1.52 billion in 2024 to USD 5.05 billion by 2034, achieving a CAGR of 12.74%. In 2024, North America led the progesterone market, while Asia Pacific is set for the fastest growth. Natural formulations held the largest share, but synthetic ones will grow quickest. Inject...
November 01, 2025
According to market projections, the global ectopic pregnancy market, valued at USD 9.03 billion in 2024, is anticipated to reach USD 16.09 billion by 2034, growing at a CAGR of 5.94% over the next decade. In 2024, North America led the ectopic pregnancy market, with tubal ectopic cases and folic acid analogue treatments dominating. Retail pharmaci...
November 01, 2025
According to market projections, the hormonal replacement therapy sector is expected to grow from USD 24.26 billion in 2024 to USD 46.32 billion by 2034, reflecting a CAGR of 6.68%. In 2024, North America led the hormonal replacement therapy market with a 40% share, while Asia Pacific is set for the fastest growth. Estrogen and progesterone therapy...
November 01, 2025
Market insights predict the global gynecological devices industry will increase from USD 11.03 billion in 2024 to USD 25.36 billion by 2034, achieving a CAGR of 8.68%. In 2024, North America led the gynecological devices market with a 39% share, while Asia-Pacific is set for the fastest growth. Surgical devices dominated and will expand rapidly thr...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com